Acute Neurofunctional Effects of Escitalopram in Pediatric Anxiety: A Double-Blind, Placebo-Controlled Trial-Reference-Cited by-同舟云学术

Acute Neurofunctional Effects of Escitalopram in Pediatric Anxiety: A Double-Blind, Placebo-Controlled Trial

Published:2021-10 Issue:10 Volume:60 Page:1309-1318
ISSN:0890-8567
Container-title:Journal of the American Academy of Child & Adolescent Psychiatry
language:en
Short-container-title:Journal of the American Academy of Child & Adolescent Psychiatry

Author:

Lu Lu^ORCID,Mills Jeffrey A.^ORCID,Li Hailong^ORCID,Schroeder Heidi K.,Mossman Sarah A.^ORCID,Varney Sara T.,Cecil Kim M.^ORCID,Huang Xiaoqi^ORCID,Gong Qiyong^ORCID,Ramsey Laura B.^ORCID,DelBello Melissa P.^ORCID,Sweeney John A.^ORCID,Strawn Jeffrey R.^ORCID

Funder

National Institute of Environmental Health Sciences

National Natural Science Foundation of China

National Institute of Mental Health

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Developmental and Educational Psychology

Reference56 articles.

1. Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety;Walkup;N Engl J Med,2008

2. Efficacy and tolerability of antidepressants in pediatric anxiety disorders: a systematic review and meta-analysis;Strawn;Depress Anxiety,2015

3. Placebo response in pediatric anxiety disorders: results from the Child/Adolescent Anxiety Multimodal Study;Strawn;J Child Adolesc Psychopharmacol,2017